Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 USD | -23.08% | -1.89% | -1.23% |
Financials (USD)
Sales 2024 * | 55.47M | Sales 2025 * | 11.82M | Capitalization | 79.16M |
---|---|---|---|---|---|
Net income 2024 * | -46M | Net income 2025 * | -102M | EV / Sales 2024 * | 1.43 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.7 x |
P/E ratio 2024 * |
-2.58
x | P/E ratio 2025 * |
-1.27
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.47% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | -23.08% | ||
1 week | -1.89% | ||
Current month | -9.84% | ||
1 month | -5.88% | ||
3 months | +24.98% | ||
6 months | +59.05% | ||
Current year | -1.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.8 | -23.08% | 2,279,574 |
24-05-23 | 1.04 | +6.12% | 1,652,899 |
24-05-22 | 0.98 | +14.34% | 2,167,001 |
24-05-21 | 0.8571 | -0.22% | 567,738 |
24-05-20 | 0.859 | +5.35% | 451,551 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.23% | 79.16M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- HOOK Stock